Crossmark Global Holdings’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-18,865
Closed -$449K 1320
2023
Q3
$449K Buy
18,865
+257
+1% +$4.84K 0.01% 861
2023
Q2
$301K Hold
18,608
0.01% 1071
2023
Q1
$324K Sell
18,608
-114
-0.6% -$2.05K 0.01% 1014
2022
Q4
$352K Buy
18,722
+120
+0.6% +$2.31K 0.01% 955
2022
Q3
$330K Buy
18,602
+174
+0.9% +$3.02K 0.01% 945
2022
Q2
$321K Buy
+18,428
New +$351K 0.01% 1003
2019
Q4
Sell
-10,070
Closed -$158K 1447
2019
Q3
$158K Buy
10,070
+10
+0.1% +$166 ﹤0.01% 1300
2019
Q2
$200K Sell
10,060
-546
-5% -$10.2K 0.01% 1311
2019
Q1
$178K Sell
10,606
-90
-0.8% -$1.56K 0.01% 1338
2018
Q4
$162K Sell
10,696
-8,380
-44% -$144K 0.01% 1336
2018
Q3
$383K Buy
19,076
+340
+2% +$7.21K 0.01% 1146
2018
Q2
$365K Buy
18,736
+620
+3% +$9.8K 0.01% 1163
2018
Q1
$247K Sell
18,116
-1,666
-8% -$21.9K 0.01% 1389
2017
Q4
$269K Buy
+19,782
New +$284K 0.01% 1433

Other funds holding NXGN

Crossmark Global Holdings's NXGN Position: Q4 2023 in Review

Crossmark Global Holdings sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2023, closing a stake of 18,865 shares — an estimated $449K sold.

Crossmark Global Holdings first reported a position in NXGN in Q4 2017 and held it in 14 quarters. The position peaked at $449K in Q3 2023. 1 fund tracked by Wall St. Rank holds NXGN as of Q4 2023.

  • Crossmark Global Holdings reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Crossmark Global Holdings sold 18,865 NextGen Healthcare, Inc. Common Stock shares in Q4 2023, an estimated $449K.
  • Crossmark Global Holdings first reported a position in NextGen Healthcare, Inc. Common Stock in Q4 2017 and held it in 14 quarters.
  • Crossmark Global Holdings's NextGen Healthcare, Inc. Common Stock position peaked at $449K in Q3 2023.
  • 1 fund tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2023.

Based on Crossmark Global Holdings's 13F filing for Q4 2023, filed 13 Feb 2024.